124 related articles for article (PubMed ID: 32385351)
1. Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16-/CD16 + monocyte ratio.
Zhang W; Ruan J; Zhou D; Han X; Zhang Y; Wang W; Ouyang M
Sci Rep; 2020 May; 10(1):7757. PubMed ID: 32385351
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implication of leucocyte subpopulations in diffuse large B-cell lymphoma.
Han X; Ruan J; Zhang W; Zhou D; Xu D; Pei Q; Ouyang M; Zuo M
Oncotarget; 2017 Jul; 8(29):47790-47800. PubMed ID: 28548962
[TBL] [Abstract][Full Text] [Related]
3. Elevated circulating CD14
Peng A; Ke P; Zhao R; Lu X; Zhang C; Huang X; Tian G; Huang J; Wang J; Invernizzi P; Chen Q; Zhuang J
Clin Exp Med; 2016 Nov; 16(4):511-521. PubMed ID: 26403460
[TBL] [Abstract][Full Text] [Related]
4. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography.
Rogacev KS; Cremers B; Zawada AM; Seiler S; Binder N; Ege P; Große-Dunker G; Heisel I; Hornof F; Jeken J; Rebling NM; Ulrich C; Scheller B; Böhm M; Fliser D; Heine GH
J Am Coll Cardiol; 2012 Oct; 60(16):1512-20. PubMed ID: 22999728
[TBL] [Abstract][Full Text] [Related]
5. Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts.
Komano Y; Nanki T; Hayashida K; Taniguchi K; Miyasaka N
Arthritis Res Ther; 2006; 8(5):R152. PubMed ID: 16987426
[TBL] [Abstract][Full Text] [Related]
6. Circulating CD14
Meeuwsen JAL; de Vries JJ; van Duijvenvoorde A; van der Velden S; van der Laan SW; van Koeverden ID; van de Weg SM; de Borst GJ; de Winther MPJ; Kuiper J; Pasterkamp G; Hoefer IE; de Jager SCA;
J Mol Cell Cardiol; 2019 Feb; 127():260-269. PubMed ID: 30629987
[TBL] [Abstract][Full Text] [Related]
7. A Novel, Five-Marker Alternative to CD16-CD14 Gating to Identify the Three Human Monocyte Subsets.
Ong SM; Teng K; Newell E; Chen H; Chen J; Loy T; Yeo TW; Fink K; Wong SC
Front Immunol; 2019; 10():1761. PubMed ID: 31402918
[TBL] [Abstract][Full Text] [Related]
8. CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease.
Rogacev KS; Seiler S; Zawada AM; Reichart B; Herath E; Roth D; Ulrich C; Fliser D; Heine GH
Eur Heart J; 2011 Jan; 32(1):84-92. PubMed ID: 20943670
[TBL] [Abstract][Full Text] [Related]
9. Circulating classical CD14++CD16- monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163.
Lapuc I; Bolkun L; Eljaszewicz A; Rusak M; Luksza E; Singh P; Miklasz P; Piszcz J; Ptaszynska-Kopczynska K; Jasiewicz M; Kaminski K; Dabrowska M; Bodzenta-Lukaszyk A; Kloczko J; Moniuszko M
Oncol Rep; 2015 Sep; 34(3):1269-78. PubMed ID: 26135617
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD206 and CD163 on intermediate CD14
Li X; Du N; Xu G; Zhang P; Dang R; Jiang Y; Zhang K
Virus Res; 2018 Jul; 253():92-102. PubMed ID: 29857122
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility and response of human blood monocyte subsets to primary dengue virus infection.
Wong KL; Chen W; Balakrishnan T; Toh YX; Fink K; Wong SC
PLoS One; 2012; 7(5):e36435. PubMed ID: 22574162
[TBL] [Abstract][Full Text] [Related]
12. CD16
Wacleche VS; Cattin A; Goulet JP; Gauchat D; Gosselin A; Cleret-Buhot A; Zhang Y; Tremblay CL; Routy JP; Ancuta P
Blood Adv; 2018 Nov; 2(21):2862-2878. PubMed ID: 30381402
[TBL] [Abstract][Full Text] [Related]
13. CD16+ and CD16- human blood monocyte subsets differentiate in vitro to dendritic cells with different abilities to stimulate CD4+ T cells.
Sánchez-Torres C; García-Romo GS; Cornejo-Cortés MA; Rivas-Carvalho A; Sánchez-Schmitz G
Int Immunol; 2001 Dec; 13(12):1571-81. PubMed ID: 11717198
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor expression on classic and pro-inflammatory blood monocytes after acute exercise in humans.
Simpson RJ; McFarlin BK; McSporran C; Spielmann G; ó Hartaigh B; Guy K
Brain Behav Immun; 2009 Feb; 23(2):232-9. PubMed ID: 18930806
[TBL] [Abstract][Full Text] [Related]
15. Monocyte subtypes predict clinical course and prognosis in human stroke.
Urra X; Villamor N; Amaro S; Gómez-Choco M; Obach V; Oleaga L; Planas AM; Chamorro A
J Cereb Blood Flow Metab; 2009 May; 29(5):994-1002. PubMed ID: 19293821
[TBL] [Abstract][Full Text] [Related]
16. Elevated CD14++CD16- monocytes predict cardiovascular events.
Berg KE; Ljungcrantz I; Andersson L; Bryngelsson C; Hedblad B; Fredrikson GN; Nilsson J; Björkbacka H
Circ Cardiovasc Genet; 2012 Feb; 5(1):122-31. PubMed ID: 22238190
[TBL] [Abstract][Full Text] [Related]
17. CD16+ monocytes exposed to HIV promote highly efficient viral replication upon differentiation into macrophages and interaction with T cells.
Ancuta P; Kunstman KJ; Autissier P; Zaman T; Stone D; Wolinsky SM; Gabuzda D
Virology; 2006 Jan; 344(2):267-76. PubMed ID: 16305804
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of CD16- monocyte subsets in systemic lupus erythematous patients.
Wu Z; Zhang S; Zhao L; Fei Y; Wang L; Li J; Wen X; Zeng X; Zhang F; Li Y
Clin Rheumatol; 2017 Oct; 36(10):2281-2287. PubMed ID: 28821990
[TBL] [Abstract][Full Text] [Related]
19. The "Intermediate" CD14
Wildgruber M; Aschenbrenner T; Wendorff H; Czubba M; Glinzer A; Haller B; Schiemann M; Zimmermann A; Berger H; Eckstein HH; Meier R; Wohlgemuth WA; Libby P; Zernecke A
Sci Rep; 2016 Dec; 6():39483. PubMed ID: 27991581
[TBL] [Abstract][Full Text] [Related]
20. Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions.
Ancuta P; Moses A; Gabuzda D
Immunobiology; 2004; 209(1-2):11-20. PubMed ID: 15481136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
